Publication | Closed Access
Patient Outcomes Following Micropulse Transscleral Cyclophotocoagulation: Intermediate-term Results
103
Citations
24
References
2018
Year
Our large longitudinal cohort study has provided evidence that MPTSCPC is a safe and generally effective option in the treatment of POAG up to 12 months.
| Year | Citations | |
|---|---|---|
Page 1
Page 1